Home Positions Contact Us Map
עברית
Kits for Labeling with 99mTC DTPA MDP TechneScan® kits for labelling with 99mTc | Lung TechneScan® kits for labelling with 99mTc | Kidney DMSA Kits for labelling with 99mTC| Blood GH RBC Cardiolite® kits for labelling with 99mTC Neurolite® kits for labelling with 99mTC Kit for 99mTc Labeled DIPA Tc-DIPA Radionuclides and Radiopharmaceuticals Contrast Media for MRI

Cardiolite® kits for labelling with 99mTC

Indication

- Myocardial perfusion scintigraphy

- Breast imaging for the evaluation of breast lesions in patients with an abnormal

mammogram or a palpable breast mass

Storage
Room temperature
Composition

Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetrafluoroborate—1.0 mg

Sodium Citrate Dihydrate—2.6 mg

L-Cysteine Hydrochloride Monohydrate—1.0 mg

Mannitol—20 mg

Stannous Chloride, Dihydrate, minimum (SnCl2•2H2O)—0.025 mg

Stannous Chloride, Dihydrate (SnCl2•2H2O)—0.075 mg

Reconstitution

925-5550 MBq, (25–150 mCi) in approximately 1 to 3 mL.

Incubation
10 minutes in boiling water
Labelling yield
≥ 90%
Stability after labelling
6 hours
pH
5.0 – 6.0
Cardiolite® kits for labelling with <sup>99m</sup>TC: Usage